Thiamine Hydrochloride Injection, Solution
Product Images NDC 68083-567

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiamine Hydrochloride (NDC 68083-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiamine-spl-carton (Thiamine Spl Carton)

This text appears to be a pharmaceutical product label for Thiamine HCI Injection, USP. It contains relevant information such as dosage instructions, storage conditions, and manufacturing details. The product is intended for intramuscular or intravenous use, and each 2 mL vial contains 200 mg of Thiamine HCI. It is advised to store the product between 20° to 25° C (68° to 77°F) and protect it from light. The label also provides information on the ingredients in the solution and emphasizes the importance of checking the solution before use. Additionally, it mentions that the product contains no more than 400 micrograms/L of aluminum.*

FDA Label Image

Thiamine-spl-structure (Thiamine Spl Structure)

FDA Label Image

Thiamine-spl-vial (Thiamine Spl Vial)

This is a description for Thiamine HCI injection, USP with a concentration of 200 mg per 2 mL in a multiple dose vial for intramuscular or intravenous use. The medication is manufactured by Gland Pharma Limited in Hyderabad, India. It is important to protect the product from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.